DALLAS and BOONTON, N.J., Aug. 27, 2019 /PRNewswire/ -- SWK Holdings Corporation (SWKH.OB) ("SWK" or the "Company"), a life science focused specialty finance company, and Enteris BioPharma, Inc.
DALLAS, Nov. 21, 2019 /PRNewswire/ -- SWK Holdings Corporation (SWKH.OB) ("SWK" or the "Company"), a life science focused specialty finance company, announced today that Winston Black, Chief Executive ...
PDL BioPharma Announces Sale of Kybella®, Zalviso® and Coflex® Royalties to SWK Holdings Corporation
INCLINE VILLAGE, Nev., Aug. 31, 2020 /PRNewswire/ -- PDL BioPharma, Inc. ("PDL" or the "Company") (Nasdaq: PDLI) announces the signing and closing of a definitive agreement for the sale of three ...
Stanley Black & Decker, Inc. SWK is scheduled to release second-quarter 2022 results on Jul 28, before market open. The Zacks Consensus Estimate for SWK’s second-quarter earnings has been revised ...
SWK Holdings (SWKH) has shifted its strategy by selling royalty assets, paying a special dividend, and focusing on loan growth and pharmaceutical development. Despite a slight revenue decline, SWKH ...
Manufacturing company Stanley Black & Decker (NYSE:SWK) beat Wall Street’s revenue expectations in Q1 CY2025, but sales fell by 3.2% year on year to $3.74 billion. Its non-GAAP profit of $0.75 per ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback